|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.35 EUR | -2.76% |
|
-5.36% | -53.13% |
| 07-03 | Newron Pharmaceuticals to Make Changes to Phase 3 Trial of Schizophrenia Treatment | MT |
| 05-05 | Edison Is Not Overly Concerned About a Trial Suspension |  |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- NWRN Stock
- NP5 Stock
- Charts Newron Pharmaceuticals S.p.A.
Select your edition
All financial news and data tailored to specific country editions
